Publicaciones en colaboración con investigadores/as de Universitat de València (10)

2022

  1. Screening of substance use and mental health problems among Spanish medical students: A multicenter study

    Journal of affective disorders, Vol. 311, pp. 391-398

2016

  1. Diagnosis and neurocognitive profiles in first-episode non-affective psychosis patients

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 266, Núm. 7, pp. 619-628

2013

  1. Course of cognitive deficits in first episode of non-affective psychosis: A 3-year follow-up study

    Schizophrenia Research, Vol. 150, Núm. 1, pp. 121-128

  2. Long-term (3-year) neurocognitive effectiveness of antipsychotic medications in first-episode non-affective psychosis: A randomized comparison of haloperidol, olanzapine, and risperidone

    Psychopharmacology, Vol. 227, Núm. 4, pp. 615-625

  3. Predictors of neurocognitive impairment at 3years after a first episode non-affective psychosis

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 43, pp. 23-28

2012

  1. Homocysteine and cognition in first-episode psychosis patients

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 262, Núm. 7, pp. 557-564

  2. Validación de la versión en castellano de la Escala del Bienestar Subjetivo con Neurolépticos (SWN-K) en pacientes con esquizofrenia

    Medicina Clinica, Vol. 138, Núm. 4, pp. 151-154

2011

  1. Global and regional cortical thinning in first-episode psychosis patients: Relationships with clinical and cognitive features

    Psychological Medicine, Vol. 41, Núm. 7, pp. 1449-1460

  2. Impact of depressive symptoms on subjective well-being: The importance of patient-reported outcomes in schizophrenia

    Patient Preference and Adherence, Vol. 5, pp. 471-474

  3. Sex-specific variation of MRI-based cortical morphometry in adult healthy volunteers: The effect on cognitive functioning

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 35, Núm. 2, pp. 616-623